Resonant Acquires Creapharm Bioservices to Expand EU Biobank Reach
Image
Leesburg, Va. – September 09, 2026 -- Resonant Clinical Solutions has acquired France-based Creapharm Bioservices from Myonex, expanding its cryogenic storage and biobanking capabilities across Europe to support increasingly complex cell and gene therapy trials.
Deal adds specialized cryogenic infrastructure in France
Creapharm Bioservices, headquartered in Bailly-Romainvilliers, France, provides biobanking and cryogenic storage services for biotherapeutics, advanced therapy medicinal products (ATMPs) and biological samples. Its capabilities include liquid nitrogen storage down to -196°C, mechanical freezing, cold storage, GMP-compliant sample storage and GDP-compliant custody for quality control. Financial terms of the transaction were not disclosed.